Biopharmaceutical Analysis & Statistics in North America Countries, October 2011 (p7)

You might be interested in: protein, biomedical, antibody, more »

181-210 of about 300 reports

Purchase Reports From Reputable Market Research Publishers

Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

  • $ 1 200
  • Industry report
  • October 2011
  • by International Market Analysis Research and Consult

With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule generics, ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Biologics  Market

US Biologics  Market

  • $ 4 900
  • Industry report
  • October 2011
  • by Freedonia

US demand to exceed $100 billion by 2015 Demand for biologics will exceed $100 billion in 2015, experiencing continuing strong growth following a decade of double-digit annual increases. Continued growth ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research

Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research

  • $ 6 000
  • Industry report
  • September 2011
  • by Frost & Sullivan

This research service analyzes the market for protein purification reagents with market sizing and forecasts for sales of tagged protein purification reagents and nontagged protein purification reagents. ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - H2 2011

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • September 2011
  • by Global Markets Direct

s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • September 2011
  • by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
Micromet, Inc.- Strategy and SWOT Report

Micromet, Inc.- Strategy and SWOT Report

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

Micromet, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pfizer Inc. SWOT

Pfizer Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Pfizer is the world's premier biopharmaceutical industry ...

  • Industries : Biopharmaceutical
  • Countries : United States
Micromet, Inc. SWOT

Micromet, Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Micromet is a biopharmaceutical industry player focused ...

  • Industries : Biopharmaceutical
  • Countries : United States
Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Overview

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Overview

  • $ 3 195
  • Industry report
  • July 2011
  • by CHI Insight Pharma Reports

By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of protein engineering. This report discusses new ...

  • Industries : Biopharmaceutical
  • Countries : United States
The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market

The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market

  • $ 3 900
  • Industry report
  • May 2011
  • by CBR Pharma Insights

Biosimilars are attracting significant attention at present as companies from all sectors of the biopharmaceutical market are investigating the opportunities they present. Opinion is split as to the true ...

  • Industries : Biopharmaceutical
  • Countries : Europe, World, United States
What%s Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

What%s Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

  • $ 3 995
  • Industry report
  • May 2011
  • by Kalorama Information

The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

Datamonitors' ZymoGenetics, Inc.?s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, ...

  • Industries : Biopharmaceutical
  • Countries : United States
ZymoGenetics, Inc. SWOT

ZymoGenetics, Inc. SWOT

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Industry: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - Q1 2011

Biopharmaceutical Industry: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q1 2011

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

  • $ 3 500
  • Industry report
  • March 2011
  • by GBI Research

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, ?Upstream Processing in Biopharmaceuticals ...

  • Industries : Biopharmaceutical
  • Countries : United States, Japan, India
Monoclonal Antibodies: A Segment of Major Growth

Monoclonal Antibodies: A Segment of Major Growth

  • $ 3 195
  • Industry report
  • March 2011
  • by CHI Insight Pharma Reports

Monoclonal antibodies are highly valuable therapeutic agents and were among the best-selling drugs in the world in 2010. Global revenues from monoclonal antibody products will have moved significantly ...

  • Industries : Biopharmaceutical
  • Countries : United States
Competitor Analysis Cancer Antibodies in Early Clinical Develoment

Competitor Analysis Cancer Antibodies in Early Clinical Develoment

  • $ 1 188
  • Industry report
  • February 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Cancer Antibodies in Early Clinical Development provides a competitor evaluation in the field of antibody therapeutics being developed ...

  • Industries : Biopharmaceutical
  • Countries : United States
Competitor Analysis Erythropoietin (EPO)

Competitor Analysis Erythropoietin (EPO)

  • $ 660
  • Industry report
  • January 2011
  • by La Merie Publishing

Product description The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second ...

  • Industries : Biopharmaceutical
  • Countries : India, World, Mexico, China
Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

This report provides data on the therapeutic development for Growth Hormone Deficiency   , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

  • $ 3 500
  • Industry report
  • December 2010
  • by GBI Research

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions Summary GBI Research, the leading business intelligence provider, has released its latest ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Japan, Europe
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Antibody Technology Companies 2010 -  A systematic guide through the landscape of antibody technologies and their providers

Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers

  • $ 1 313
  • Industry report
  • November 2010
  • by La Merie Publishing

The report ?Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers? provides a description and assessment of antibody technologies and ...

  • Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : United States
Food Safety Testing: Technologies and Markets

Food Safety Testing: Technologies and Markets

  • $ 6 650
  • Industry report
  • September 2010
  • by BCC Research

The total U.S. food safety testing market is valued at $3.4 billion in 2010 and is projected to increase at a 6.6% compound annual growth rate (CAGR) over the next 5 years.  The total sector market value ...

  • Industries : Biopharmaceutical, Genetically Modified Organism, Gmo, Food
  • Countries : United States
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

  • $ 3 500
  • Industry report
  • September 2010
  • by GBI Research

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Summary GBI Research's report, ?Manufacturing ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Japan, United States, India, Singapore, China, World, Europe, Asia
Ubiquitin Proteosome Drugs: Cancer and Neurodegenerative Disorder Markets

Ubiquitin Proteosome Drugs: Cancer and Neurodegenerative Disorder Markets

  • $ 6 650
  • Industry report
  • July 2010
  • by BCC Research

There is only one approved UPS product on the market, Velcade, a proteasome inhibitor, with total sales of more than $1.4 billion in 2009. This drug is expected to be worth $3 billion in 2015, a compound ...

  • Industries : Drug Discovery and Development, Drug and Medication, Biopharmaceutical
  • Countries : World, United States
Competitor Analysis: Streptococcal Vaccines and Antibodies

Competitor Analysis: Streptococcal Vaccines and Antibodies

  • $ 264
  • Industry report
  • June 2010
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Streptococcal Vaccines & Antibodies provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States
Whey Proteins Industry

Whey Proteins Industry

  • $ 4 500
  • Industry report
  • June 2010
  • by Global Industry Analysts

This report analyzes the US and European Markets for Whey Proteins in US$ Million. The US market is also analyzed by volume (Million Pounds (lbs)). The US market is further analyzed by the following product ...

  • Industries : Biopharmaceutical, Alternative Medicine, Diet Food
  • Countries : United States
7th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

7th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • $ 845
  • Industry report
  • April 2010
  • by BioPlan Associates, Inc.

This comprehensive look at the state of worldwide biopharmaceutical manufacturing provides the only on-going assessment of manufacturing capacity and production in this $120 billion global industry. You ...

  • Industries : Biopharmaceutical
  • Countries : United States, Europe, World
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape

Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape

  • $ 3 500
  • Industry report
  • February 2010
  • by GBI Research

Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape Summary GBI Research, the leading business intelligence ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : Europe, North America, World, United States, Canada
About 1 600 reports

Download Unlimited Documents from Trusted Public Sources

Global Vaccine Industry

  • Vaccines and Global Health: the Week in Review 20 September 2014...
  • September 2014
    53 pages
  • Vaccine  

  • United States  

    World  

    Africa  

View report >

Vaccine Market In The Us

September 2014

Vaccine Market In The Us

September 2014

4 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.